A Cost-Effectiveness Analysis of Malaria Prevention among Pregnant Cameroonian Women

Last updated September 2009
Abstract:
We analyzed the cost effectiveness of weekly chloroquine and Amodiaquine chemoprophylaxis and including IPT assuming that primigravid women are given three doses of SP at a prenatal clinic. Effectiveness attributable to these drug regimens is reduction of low birth weights and malaria related mortality among newborns. For the three prophylactic drug regimens, the SP regimen is the most effective strategy for reducing low birth weight and deaths among babies associated with malaria. The three-dose sulfadoxine pyrimethamine(SP) prevents a proportion of 0.011 of discounted year life gained or death averted as against 0.0104 and 0.0100 for the Amodiaquine (AQ) and chloroquine(CQ) regimen respectively. The costs-effectiveness ratios per primigravida were 283, 400 and 416 for the SP, AQ and CQ regimen respectively, an indication that the SP regimen is more cost-effective.
 
Contact Information:
Tabi Atemnkeng Johannes, Faculty of Economics and Management, University of Dschang and Ministry of Public Health, Cameroon
Use module action menu to edit content

Comments